Tag: Alzheimer’s disease treatment options
Axsome submits Alzheimer’s disease drug for FDA approval after Phase 3 trials
Axsome Submits Alzheimer’s Disease Drug for FDA Approval
Axsome Therapeutics, a New York-based biotech company, is forging ahead with its plans to seek FDA approval for its Alzheimer’s disease treatment, AXS-05, following results from Phase...
